Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease
- 14 October 2025
- 2 weeks ago
Rs 1.91 crore Pharma Freebies case under review: NMC
- 04 October 2025
- 4 weeks ago
AbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels
- 30 September 2025
- 1 month ago
AbbVie submits new drug application to USFDA for Tavapadon for Parkinsons disease
- 28 September 2025
- 1 month ago
No Generics for AbbVie's Rinvoq Until 2037, Analysts See Multi-Billion Dollar Boost
- 13 September 2025
- 1 month ago
AbbVie Unveils Produodopa For Advanced Parkinson'S Disease In EU
- 21 July 2025
- 3 months ago
Recent News
Himachal notifies Resident doctor policy 2025
- 02 November, 2025
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Aadhaar authentication voluntary for NBE exams, cl...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.






